KEAP1 and cancer: Knockdown of Keap1 reduces cyclin D1 and cancer stem cell markers, whereas it enhances PPARγ in chemotherapeutic agent arsenic trioxide-administered A549 cells [29], suggesting that Keap1 modulation is associated with the regulation of chemosensitivity.